labetalol has been researched along with Urinary Bladder, Overactive in 1 studies
Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.
Urinary Bladder, Overactive: Symptom of overactive detrusor muscle of the URINARY BLADDER that contracts with abnormally high frequency and urgency. Overactive bladder is characterized by the frequent feeling of needing to urinate during the day, during the night, or both. URINARY INCONTINENCE may or may not be present.
Excerpt | Relevance | Reference |
---|---|---|
"SHRs (n = 6) showed the features of overactive bladder syndrome during urodynamic study, especially DO during the filling phase." | 1.38 | Nonselective blocking of the sympathetic nervous system decreases detrusor overactivity in spontaneously hypertensive rats. ( Choi, BH; Choo, GY; Jin, LH; Kim, KH; Kwak, J; Lee, HJ; Lee, T; Park, CS; Yoon, SM, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kim, KH | 1 |
Jin, LH | 1 |
Choo, GY | 1 |
Lee, HJ | 1 |
Choi, BH | 1 |
Kwak, J | 1 |
Yoon, SM | 1 |
Park, CS | 1 |
Lee, T | 1 |
1 other study available for labetalol and Urinary Bladder, Overactive
Article | Year |
---|---|
Nonselective blocking of the sympathetic nervous system decreases detrusor overactivity in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Autonomic Nervous System; Blood Pressure; Cholinergic Antagonists; | 2012 |